Literature DB >> 31832639

Regulation of the transcription factor E2F1 mRNA in ovarian granulosa cells of cattle.

Breanne C Morrell1, M Chiara Perego1, Excel Rio S Maylem1, Lingna Zhang1, Luis F Schütz1, Leon J Spicer1.   

Abstract

The E2F family of transcription factors plays an important role in the control of the cell cycle, cell proliferation, and differentiation, and their role in ovarian function is just emerging. Although some evidence suggests a possible role of E2F1 in ovarian follicular development, what regulates its production in ovarian cells is unknown. Objectives of this study were to determine whether: (i) E2F1 gene expression in granulosa cells (GCs) and theca cells (TCs) change with follicular development and (ii) E2F1 mRNA abundance in TC and GC is hormonally regulated. Using real-time PCR, E2F1 mRNA abundance in GC was 5.5-fold greater (P < 0.05) in small (SM; 1 to 5 mm) than large (LG; >8 mm) follicles, but in TC, E2F1 expression did not differ among follicle sizes. SM-follicle GC had 2.1-fold greater (P < 0.05) E2F1 mRNA than TC. In SM-follicle GC, FGF9 induced a 7.6-fold increase in E2F1 mRNA abundance; however, FGF9 did not affect (P > 0.10) abundance of E2F1 mRNA in LG-follicle TC or GC. Follicle-stimulating hormone (FSH) had no effect (P > 0.10) on E2F1 gene expression in SM- or LG-follicle GC. SM-follicle GC were concomitantly treated with insulin-like growth factor 1 (30 ng/mL), FSH (30 ng/mL), and either 0 or 30 ng/mL of FGF9 with or without 50 µM of an E2F inhibitor (E2Fi; HLM0064741); FGF9 alone increased (P < 0.05) GC numbers, whereas E2Fi alone decreased (P < 0.05) GC numbers, and concomitant treatment of E2Fi with FGF9 blocked (P < 0.05) this stimulatory effect of FGF9. Estradiol production was inhibited (P < 0.05) by FGF9 alone and concomitant treatment of E2Fi with FGF9 attenuated (P < 0.05) this inhibitory effect of FGF9. SM-follicle GC treated with E2Fi decreased (P < 0.05) E2F1 mRNA abundance by 70%. Collectively, our studies show that GC E2F1 mRNA is developmentally and hormonally regulated in cattle. Inhibition of E2F1 reduced FGF9-induced GC proliferation and attenuated FGF9-inhibited estradiol production, indicating that E2F1 may be involved in follicular development in cattle.
© The Author(s) 2019. Published by Oxford University Press on behalf of the American Society of Animal Science. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  E2F1 transcription factor; cattle; granulosa cell; ovarian follicle; theca cell

Mesh:

Substances:

Year:  2020        PMID: 31832639      PMCID: PMC6986437          DOI: 10.1093/jas/skz376

Source DB:  PubMed          Journal:  J Anim Sci        ISSN: 0021-8812            Impact factor:   3.159


  54 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 2.  E2F target genes and cell-cycle checkpoint control.

Authors:  P Lavia; P Jansen-Dürr
Journal:  Bioessays       Date:  1999-03       Impact factor: 4.345

3.  New insights into the pathogenesis of cystic follicles in cattle: microarray analysis of gene expression in granulosa cells.

Authors:  J A Grado-Ahuir; P Y Aad; L J Spicer
Journal:  J Anim Sci       Date:  2011-01-14       Impact factor: 3.159

4.  Fibroblast growth factor 9 (FGF9) regulation of cyclin D1 and cyclin-dependent kinase-4 in ovarian granulosa and theca cells of cattle.

Authors:  M L Totty; B C Morrell; L J Spicer
Journal:  Mol Cell Endocrinol       Date:  2016-11-03       Impact factor: 4.102

5.  Hormonal regulation of vascular endothelial growth factor A (VEGFA) gene expression in granulosa and theca cells of cattle1.

Authors:  Jacqueline A Nichols; Maria Chiara Perego; Luis F Schütz; Amber M Hemple; Leon J Spicer
Journal:  J Anim Sci       Date:  2019-07-02       Impact factor: 3.159

6.  Effect of insulin-like growth factors (IGF), FSH, and leptin on IGF-binding-protein mRNA expression in bovine granulosa and theca cells: quantitative detection by real-time PCR.

Authors:  J L Voge; P Y Aad; C A T Santiago; D W Goad; J R Malayer; D Allen; L J Spicer
Journal:  Peptides       Date:  2004-12       Impact factor: 3.750

7.  Deregulated expression of cloned transcription factor E2F-1 in Chinese hamster ovary cells shifts protein patterns and activates growth in protein-free medium.

Authors:  K H Lee; A Sburlati; W A Renner; J E Bailey
Journal:  Biotechnol Bioeng       Date:  1996-05-05       Impact factor: 4.530

8.  Significance of E2F-1 overexpression in epithelial ovarian cancer.

Authors:  D S Suh; M S Yoon; K U Choi; J Y Kim
Journal:  Int J Gynecol Cancer       Date:  2007-08-10       Impact factor: 3.437

9.  Expression of the E2F family of transcription factors and its clinical relevance in ovarian cancer.

Authors:  Daniel Reimer; Susann Sadr; Annemarie Wiedemair; Georg Goebel; Nicole Concin; Gerda Hofstetter; Christian Marth; Alain G Zeimet
Journal:  Ann N Y Acad Sci       Date:  2006-12       Impact factor: 5.691

10.  Non-steroidal anti-inflammatory drugs decrease E2F1 expression and inhibit cell growth in ovarian cancer cells.

Authors:  Blanca L Valle; Theresa D'Souza; Kevin G Becker; William H Wood; Yongqing Zhang; Robert P Wersto; Patrice J Morin
Journal:  PLoS One       Date:  2013-04-24       Impact factor: 3.240

View more
  2 in total

1.  Developmental and hormonal regulation of ubiquitin-like with plant homeodomain and really interesting new gene finger domains 1 gene expression in ovarian granulosa and theca cells of cattle.

Authors:  Maria Chiara Perego; Breanne C Morrell; Lingna Zhang; Luis F Schütz; Leon J Spicer
Journal:  J Anim Sci       Date:  2020-07-01       Impact factor: 3.159

2.  DNA methylation mediated RSPO2 to promote follicular development in mammals.

Authors:  Xiaofeng Zhou; Yingting He; Nian Li; Guofeng Bai; Xiangchun Pan; Zhe Zhang; Hao Zhang; Jiaqi Li; Xiaolong Yuan
Journal:  Cell Death Dis       Date:  2021-06-26       Impact factor: 8.469

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.